Perma-Fix Reports Results for Year Ended December 31, 2014 Including 33% Increase in Revenue, 120% Increase in Gross Profit, $2.2 Million of Adjusted EBITDA and $796,000 of Net Income for the Fourth Quarter of 2014 Mar 31, 2015
Perma-Fix CEO Dr. Louis F. Centofanti Appointed to Department of Commerce's Civil Nuclear Trade Advisory Committee Mar 16, 2015
Perma-Fix Medical Project Awarded $2.7 Million Grant to Advance Development of Technetium Generator for Cancer and Cardiac Imaging Jan 21, 2015
US Patent Office Issues Patent to Perma-Fix for Microporous Composite Material and Its Applications Jan 5, 2015
Perma-Fix Reports EBITDA of $3.5 Million and Net Income of $1.9 Million for the Third Quarter of 2014 Nov 6, 2014